نتایج جستجو برای: biopharmaceutical

تعداد نتایج: 1766  

2017
Kumar Sanjiv Chi-Wei Chen Rajesh Kakadiya Satishkumar Tala Sharda Suman Ming-Hsi Wu Yen-Hui Chen Tsann-Long Su Te-Chang Lee

*Molecular Medicine Program, Taiwan International Graduate Program, Academia Sinica, Taipei, Taiwan; Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan; Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Graduate Institute of Pharmaceutical Chemistr...

Journal: :QJM : monthly journal of the Association of Physicians 2010
M K Mundae A J K Ostör

The development of therapeutics is costly, time-consuming and has high attrition rates. Biopharmaceutical medications differ from traditional agents in their discovery, design, structure and formulation. Prior to marketing a drug must show efficacy and acceptable toxicity in both preclinical and clinical trials. Regulatory bodies have a pivotal role in the licensing, naming and marketing of an ...

Journal: :Pharmacological reviews 2006
Tan D Nguyen Jason M Gow Leslie W Chinn Libusha Kelly Hotcherl Jeong Conrad C Huang Doug Stryke Michiko Kawamoto Susan J Johns Elaine Carlson Travis Taylor Thomas E Ferrin Andrej Sali Kathleen M Giacomini Deanna L Kroetz

Department of Biopharmaceutical Sciences (T.D.N., J.M.G., L.W.C., L.K., A.S., K.M.G., D.L.K.), Program in Human Genetics (K.M.G., D.L.K.), and Department of Pharmaceutical Chemistry (C.C.H., D.S., M.K., S.J.J., T.E.F.) and Genomics Core Facility, Program in Human Genetics (E.J.C., T.T.), University of California, San Francisco, San Francisco, California; and Department of Molecular and Cell Bio...

2007
Yoshinori Ueno Syozo Sonoda Ryo Suzuki Masahiro Yokouchi Yasuomi Kawasoe Kazuo Maruyama Taiji Sakamoto Setsuro Komiya

Anti-tumor effect of Doxorubicin with Bubble Liposome and Ultrasound Yoshinori Ueno1, Syozo Sonoda2, Ryo Suzuki3, Masahiro Yokouchi1, Yasuomi Kawasoe1, Kazuo Maruyama3, Taiji Sakamoto2, Setsuro Komiya1 1Department of Orthopaedic Surgery, kagoshima Graduate School of Medicine and Dental Sciences, Kagoshima, Japan; 2Department of Ophthalmology, kagoshima Graduate School of Medicine and Dental Sci...

2014
Emmie Dumont Isabel Vandenheede Phu Duong Maureen Joseph

This application note describes how the Agilent Bio-Monolith Protein A column was applied to the optimization of Chinese hamster ovary cell-culture conditions to produce a recombinant monoclonal antibody with desired structural characteristics, focusing on glycosylation. The workflow demonstrates the versatility and wide applicability of the column in biopharmaceutical and biosimilar development.

2005
Xingmei Han Gene Lee Colleen Hefner Jacquelyn J. Maher Maria Almira Correia M. A. Correia

Xingmei Han, Gene Lee, Colleen Hefner, Jacquelyn J. Maher, and Maria Almira Correia Departments of Cellular & Molecular Pharmacology (XMH, MAC), Pharmaceutical Chemistry (MAC), Biopharmaceutical Sciences (MAC), and Medicine (GL, CH, JJM) and The Liver Center (XMH, MAC, GL, CH, JJM), University of California, San Francisco, CA 94143 JPET Fast Forward. Published on March 15, 2005 as DOI:10.1124/j...

2010
S. Goh R. J. Ram

Mammalian cells dominate the biopharmaceutical industry and maintaining cell viability is a limiting factor in most mammalian cell cultures. This project is focused on developing an online (in-situ) dielectric spectroscopy sensor that is capable of measuring cell viability in real-time to enable optimization of culture conditions for Chinese Hamster Ovary (CHO) cell lines in micro-bioreactors.

2013
Mahesh Chaubal

www.ondrugdelivery.com 27 In this article, Mahesh Chaubal, PhD, Senior Director, Drug Development, R&D Medical Products, Baxter Healthcare Corporation, provides a glimpse of some of the challenges faced during the development of viscous formulations of biopharmaceutical products for injection, from a formulator’s perspective, especially when the finished product is filled in a prefilled syringe...

2001
G. Buckton

Calorimetric investigations of systems of pharmaceutical interest are selectively reviewed. Attention is drawn to the need for more systematic and quantitative investigations of bioactivity, especially of synergic and antagonistic drug combinations. Formulation affects biological response (BR) and hence attention is given in this review to some of the factors that may be of biopharmaceutical im...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید